APA

Hebbar M., Di Fioré F., Conroy T., Giraud C., Gasnault L., Fournier C., Péreira R., Bouché O., Fournier P., Deligny N., Joly J., Maes P., Rad E., Michel P. & Adenis A. (20080522). Assessment of baseline clinical predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancer. : Oncology.

Chicago

Hebbar Mohamed, Di Fioré Frédéric, Conroy Thierry, Giraud Claire, Gasnault Laurent, Fournier Charles, Péreira Renata, Bouché Olivier, Fournier Peggy, Deligny Nathalie, Joly Jean-Paul, Maes Patricia, Rad Emilia, Michel Pierre and Adenis Antoine. 20080522. Assessment of baseline clinical predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancer. : Oncology.

Harvard

Hebbar M., Di Fioré F., Conroy T., Giraud C., Gasnault L., Fournier C., Péreira R., Bouché O., Fournier P., Deligny N., Joly J., Maes P., Rad E., Michel P. and Adenis A. (20080522). Assessment of baseline clinical predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancer. : Oncology.

MLA

Hebbar Mohamed, Di Fioré Frédéric, Conroy Thierry, Giraud Claire, Gasnault Laurent, Fournier Charles, Péreira Renata, Bouché Olivier, Fournier Peggy, Deligny Nathalie, Joly Jean-Paul, Maes Patricia, Rad Emilia, Michel Pierre and Adenis Antoine. Assessment of baseline clinical predictive factors of response to cetuximab-irinotecan in patients with irinotecan-refractory metastatic colorectal cancer. : Oncology. 20080522.